Health & Fitness
Tue, September 11, 2012
TAMPA, Fla.--([ BUSINESS WIRE ])--[ Oragenics, Inc ]. (OTCQB: ORNI) (the aCompanya) a world leader in oral health probiotics and systemic antibiotics, announced today that John N. Bonfiglio, President and CEO of Oragenics, will be presenting an update of the Company at the Rodman and Renshaw Annual Global Investment Conference September 9-11th, 2012. Dr. Bonfiglio is scheduled to speak on Monday September 10th at 3:15 pm.
"With the recent completion of a $13M financing, Oragenics is set to execute its plan to become the world-leader in oral probiotics"
aWith the recent completion of a $13M financing, Oragenics is set to execute its plan to become the world-leader in oral probiotics,a stated Dr. Bonfiglio. aIn addition, the funding will allow us to continue and expand our work on powerful new antibiotics with our research partner Intrexon. This is a very exciting time for Oragenics. We have the funding and the team to begin to make advances on all parts of our strategy.a
About Oragenics, Inc.
Oragenics, Inc. is focused on becoming the world leader in probiotics for oral health for humans and pets and in novel antibiotics against infectious disease. Oragenics, Inc. develops, markets and sells proprietary probiotics specifically designed to enhance oral health for humans and pets, under the brand names [ Evora ] and [ ProBiora ] in over 13 countries worldwide. Oragenics, Inc. has established an exclusive worldwide channel collaboration for lantibiotics, a novel class of broad spectrum antibiotics, with Intrexon Corporation, a synthetic biology company.
For more information, visit [ www.oragenics.com ]. Follow Oragenics on [ Facebook ] and [ Twitter ].
Safe Harbor Statement: Under the Private Securities Litigation Reform Act of 1995: This release includes forward-looking statements that reflect the Companyas current views with respect to future events and financial performance. These forward-looking statements are based on managementas beliefs and assumptions and information currently available. The words abelieve,a aexpect,a aanticipate,a aintend,a aestimate,a aprojecta and similar expressions that do not relate solely to historical matters identify forward-looking statements. Investors should be cautious in relying on forward-looking statements because they are subject to a variety of risks, uncertainties, and other factors that could cause actual results to differ materially from those expressed in any such forward-looking statements. These factors include, but are not limited to our ability to raise additional capital to sustain our operations beyond June 30, 2012 and those set forth in our most recently filed annual report on Form 10-K and quarterly report on Form 10-Q, and other factors detailed from time to time in filings with the U.S. Securities and Exchange Commission. We expressly disclaim any responsibility to update forward-looking statements.
Photos/MultimediaGallery Available: [ http://www.businesswire.com/cgi-bin/mmg.cgi?eid=50401641&lang=en ]
